No Vaccine For Latest Ebola Outbreak, DRC Warns As Death Toll Hits 80
No Vaccine For Latest Ebola Outbreak, DRC Warns As Death Toll Hits 80
Health authorities in Democratic Republic of the Congo have raised fresh concerns over a new Ebola outbreak after confirming that there is currently no vaccine or specific treatment for the Bundibugyo strain responsible for the latest infections.
The country’s Health Minister, Samuel-Roger Kamba, disclosed this during a press briefing in Kinshasa on Saturday.
According to him, the strain has a “very high lethality rate” which could reach 50 percent.
“The Bundibugyo strain has no vaccine, no specific treatment,” Kamba stated while addressing journalists.
Officials also confirmed that the death toll from the outbreak had risen to 80, up from the 65 deaths initially reported a day earlier.
The latest outbreak has already spread beyond the DRC, with neighbouring Uganda recording one fatality linked to the virus.
Ugandan health authorities said the victim, a 59-year-old Congolese national, died in Kampala after being admitted earlier in the week. His body was later repatriated to the DRC.
Medical tests reportedly confirmed that the deceased was infected with the Bundibugyo strain of Ebola, first identified in 2007.
Health experts explained that existing Ebola vaccines are only effective against the Zaire strain, which was first discovered in 1976 and has an even higher fatality rate ranging between 60 and 90 percent.
The latest outbreak was officially confirmed in Ituri Province in northeastern DRC, a region bordering Uganda and South Sudan.
The Africa Centres for Disease Control and Prevention had earlier warned about the outbreak, citing concerns over significant cross-border movement in the affected region.
According to Kamba, the index patient was a nurse who visited a health facility in Bunia, the provincial capital of Ituri, on April 24 with symptoms associated with Ebola.
Authorities fear the movement of people across borders could increase the risk of wider regional transmission if urgent containment measures are not strengthened.
Health officials in both countries have intensified surveillance, contact tracing and emergency response efforts to contain the spread of the deadly virus.
Related stories
Health
Senegal’s $7.1m Sickle Cell Drug Push Targets Six African Markets
Senegalese firm Teranga Pharma is expanding production of Drepaf, a locally manufactured generic hydroxyurea for sickle cell disease, backed by a $7.1 million project, and targeting six African markets with a goal of supplying sub-Saharan Africa by 2030
Health
20–30% of Katsina Diphtheria Patients May Die, State’s NMA Chair Warns
The NMA Katsina chair, Dr Mohammed Abubakar, says two to three of every 10 diphtheria patients admitted to Federal Teaching Hospital Katsina may die, as the state records over 1,000 suspected cases across 29 LGAs amid antitoxin shortages.
Health
Health Insurance Enrolment Rises but Coverage Gap Persists
Nigeria’s health insurance enrolment has climbed to 22.03 million by July 2026, a 35 per cent year-on-year rise, yet millions remain uncovered and exposed to high out-of-pocket costs, with structural barriers slowing the march to universal health coverage
Health
Diphtheria Outbreak Spreads to 29 Katsina LGAs as Kano Confirms Two More Deaths
Katsina State says suspected diphtheria cases have now spread to 29 of its 34 local government areas, with Funtua worst-hit, as neighbouring Kano confirms two fresh deaths in Rano LGA and the Federal Government deploys 500,000 vaccine doses to both states.
Comments (0)
Leave a comment
All comments are moderated before publishing. Your email is never published.